(Q34615890)

English

Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Audrey Arfi

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Magali Richard

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Christelle Gandolphe

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Daniel Scherman

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Journal of Inherited Metabolic Disease

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

61-67

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10545-009-9029-2

21 January 2018

Genetic toxicity studies with genistein

1 reference

https://api.crossref.org/works/10.1007%2FS10545-009-9029-2

21 January 2018

Flavonoids: a review of probable mechanisms of action and potential applications

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: An open-label, pilot study in 10 pediatric patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy in a murine model of Morquio A syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycomics: an integrated systems approach to structure-function relationships of glycans

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different amounts of isoflavones in various commercially available soy extracts in the light of gene expression-targeted isoflavone therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of mucopolysaccharidosis type III.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Death-associated protein (DAP) kinase plays a central role in ceramide-induced apoptosis in cultured hippocampal neurons

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sanfilippo syndrome: a mini-review

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stop-codon read-through for patients affected by a lysosomal storage disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A block of autophagy in lysosomal storage disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of new markers for neurodegeneration process in the mouse model of Sly disease as revealed by expression profiling of selected genes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A chaperone-mediated approach to enzyme enhancement as a therapeutic option for the lysosomal storage disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent measurement of unbound genistein in the blood, brain and bile of anesthetized rats using microdialysis and its pharmacokinetic application

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Substrate reduction therapy for lysosomal storage diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme-replacement therapy in mucopolysaccharidosis I.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repeated oral once daily intake of increasing doses of the novel synthetic genistein product Bonistein in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20084460

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10545-009-9029-2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34615890&oldid=2196868071"